Akademik Veri Yönetim Sistemi
21st Congress of the European Society of Dermatology and Psychiatry & 1st World Congress of Psychodermatology, İstanbul, Türkiye, 28 - 31 Mayıs 2025, cilt.19, ss.139-140, (Özet Bildiri)
Aim: Acne is a common dermatological disease that affects individuals’ quality of life both physically and psychosocially. Existing assessment scales are inadequate in addressing these effects holistically. Therefore, the Aknedisk scale was developed, which combines the disciplines of dermatology and psychiatry to comprehensively evaluate the symptoms and psychosocial effects of acne patients. The items of the scale were determined in line with expert opinions and structured with scientific methods. Materials and Methods: The Delphi consensus method was employed to develop the scale, incorporating a multidisciplinary approach with input from dermatology and psychiatry experts. Initially, a panel of four dermatologists and four psychiatrists was assembled, and through two iterative rounds, 40 items were formulated under 10 key domains reflecting the potential effects of acne, ensuring expert consensus. Following this phase, the preliminary scale was administered via an online survey to two independent expert groups, each comprising 25 dermatologists and 25 psychiatrists. Participants evaluated each item on a 1-5 Likert scale, rating their appropriateness. Statistical analyses were conducted to determine consensus levels, and the highest-scoring item within each domain was selected, resulting in the final 10-item Aknedisk scale. Results: As a result of the data analysis, 10 items that experts agreed on the most among 40 items determined under 10 headings were selected and included in the scale. The selected items cover areas such as general health status of acne, physical appearance, symptoms, mental health, sexual health, social life, work/daily activities, sleep, shame/stigma and disease control. A high consensus was reached on the effects of acne especially on physical appearance, mental health and social life, and it was observed that patients experienced loss of self-confidence and difficulty in social relationships. In addition, it was determined that acne-related symptoms negatively affected daily life and caused restlessness, tension and loss of self-confidence in patients’ mental health. Conclusion: Developed within the scope of this study, Aknedisk is a holistic scale that evaluates the physical and psychosocial effects experienced by acne patients and is shaped by the common opinions of dermatologists and psychiatrists. This scale can be used in clinical practices to evaluate the quality of life of patients and to guide treatment processes. Aknedisk can also be used during the treatment process; by following the changes in the scale scores of the patients, the psychosocial improvement obtained from the treatment can be observed. In addition, the observed reduction in disc area may be an indicator that the treatment provides both physical and psychosocial benefits. In future studies, it is recommended that the scale be tested in larger patient groups by conducting validity and reliability analyses